A Failed Acquisition Is The Best Thing That's Happened To Core Scientific

Core Scientific, Inc. rejects $9B CoreWeave bid, signaling greater growth ahead. Click for my updated look at CORZ stock ...

Tiziana Life Sciences: Foralumab's Intranasal Push Is A Good Moonshot

Tiziana Life Sciences is a buy due to its platform optionality and upcoming catalysts that outweigh its dilution risk and ...

Apple earnings recap: Stock rises 5% on earnings beat but China revenue declines

Apple's revenue and EPS exceeded estimates, but iPhone revenue and China sales missed expectations. Tim Cook talked AI and ...